| William E Passodelis, MD | |
|
1670 River Rd, Beaver, PA 15009-2412 | |
| (724) 774-5227 | |
| Not Available |
| Full Name | William E Passodelis |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 32 Years |
| Location | 1670 River Rd, Beaver, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982644431 | NPI | - | NPPES |
| 102974130 | Medicaid | PA | |
| 751180 | Other | OH | BUCKEYE |
| 200315510 | Medicaid | IN | |
| 000000225226 | Other | OH | UNISON |
| 415018 | Other | OH | WELLCARE |
| 7692258 | Other | OH | AETNA |
| ME78324 | Other | FL | FLORIDA MEDICAL LICENSE |
| 0304914 | Other | OH | BCMH |
| 0982165 | Medicaid | OH | |
| 000000538713 | Other | OH | AMTHEM |
| P00398037 | Other | OH | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 01059792A (Indiana) | Primary |
| 2085R0202X | Radiology - Diagnostic Radiology | 35066851 (Ohio) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ohio State University State Health System | Columbus, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Osu Radiology Llc | 8921031675 | 126 |
News Archive
Embryonic stem (ES) cells, known for their capacity to proliferate indefinitely and differentiate into almost all types of cells including hepatocytes, have raised the hope of cellular replacement therapy for liver failure. There have been several protocols available for hepatic fate specification from ES cells, however, most of the protocols currently used result in low yield or purity of functional hepatocytes. Valproic acid (VPA), a histone deacetylase inhibitor, has been demonstrated to facilitate the hepatic differentiation of mesenchymal stem cells. However, little is know about whether VPA could induce the hepatic differentiation of ES cells.
"The most lamentable and heart-breaking dimension of multilateralism" is the "absence of any serious focus on gender throughout" the United Nations system, Stephen Lewis, founder of AIDS-Free World, writes in a London Independent opinion piece.
The University of Tokyo entered an agreement for developing a personalized cancer vaccine using a novel method involving the body's immune response.
The Food and Drug Administration (FDA) has approved Tykerb (lapatinib), a new targeted anti-cancer treatment, to be used in combination with capectabine (Xeloda), another cancer drug, for patients with advanced, metastatic breast cancer that is HER2 positive (tumors that exhibit HER2 protein).
› Verified 9 days ago
| Entity Name | Osu Radiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912956814 PECOS PAC ID: 8921031675 Enrollment ID: O20050914000392 |
News Archive
Embryonic stem (ES) cells, known for their capacity to proliferate indefinitely and differentiate into almost all types of cells including hepatocytes, have raised the hope of cellular replacement therapy for liver failure. There have been several protocols available for hepatic fate specification from ES cells, however, most of the protocols currently used result in low yield or purity of functional hepatocytes. Valproic acid (VPA), a histone deacetylase inhibitor, has been demonstrated to facilitate the hepatic differentiation of mesenchymal stem cells. However, little is know about whether VPA could induce the hepatic differentiation of ES cells.
"The most lamentable and heart-breaking dimension of multilateralism" is the "absence of any serious focus on gender throughout" the United Nations system, Stephen Lewis, founder of AIDS-Free World, writes in a London Independent opinion piece.
The University of Tokyo entered an agreement for developing a personalized cancer vaccine using a novel method involving the body's immune response.
The Food and Drug Administration (FDA) has approved Tykerb (lapatinib), a new targeted anti-cancer treatment, to be used in combination with capectabine (Xeloda), another cancer drug, for patients with advanced, metastatic breast cancer that is HER2 positive (tumors that exhibit HER2 protein).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William E Passodelis, MD 1670 River Rd, Beaver, PA 15009-2412 Ph: (724) 774-5227 | William E Passodelis, MD 1670 River Rd, Beaver, PA 15009-2412 Ph: (724) 774-5227 |
News Archive
Embryonic stem (ES) cells, known for their capacity to proliferate indefinitely and differentiate into almost all types of cells including hepatocytes, have raised the hope of cellular replacement therapy for liver failure. There have been several protocols available for hepatic fate specification from ES cells, however, most of the protocols currently used result in low yield or purity of functional hepatocytes. Valproic acid (VPA), a histone deacetylase inhibitor, has been demonstrated to facilitate the hepatic differentiation of mesenchymal stem cells. However, little is know about whether VPA could induce the hepatic differentiation of ES cells.
"The most lamentable and heart-breaking dimension of multilateralism" is the "absence of any serious focus on gender throughout" the United Nations system, Stephen Lewis, founder of AIDS-Free World, writes in a London Independent opinion piece.
The University of Tokyo entered an agreement for developing a personalized cancer vaccine using a novel method involving the body's immune response.
The Food and Drug Administration (FDA) has approved Tykerb (lapatinib), a new targeted anti-cancer treatment, to be used in combination with capectabine (Xeloda), another cancer drug, for patients with advanced, metastatic breast cancer that is HER2 positive (tumors that exhibit HER2 protein).
› Verified 9 days ago
Dr. Michael William Gabriele, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1000 Dutch Ridge Rd, Beaver, PA 15009 Phone: 724-773-4567 Fax: 724-728-9729 | |
Dr. Nadeem Iqbal, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1000 Dutch Ridge Rd, Beaver, PA 15009 Phone: 724-773-4567 Fax: 724-728-9729 | |
Craig Cargill Trent, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1000 Dutch Ridge Rd, Beaver, PA 15009 Phone: 724-773-4567 Fax: 724-728-9729 | |
Nimish H Patel, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1000 Dutch Ridge Rd, Beaver, PA 15009 Phone: 724-773-4567 Fax: 724-728-9729 | |
Dr. Lisa Violi Ross, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1000 Dutch Ridge Rd, Beaver, PA 15009 Phone: 724-773-4567 Fax: 724-728-9729 | |
Dr. Joel Irwin Cossrow, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1000 Dutch Ridge Rd, Beaver, PA 15009 Phone: 724-773-4567 Fax: 724-728-9729 | |
Leonard A Deriggi, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1000 Dutch Ridge Rd, Department Of Radiology, Beaver, PA 15009 Phone: 724-773-4567 Fax: 724-728-9729 |